Barclays’s CUBIST PHARMACEUTICALS INC CBST Stock Holding History

Barclays’s Portfolio CBST Stock Details CBST Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2015 Q1	–	Sell	-516,050	Closed	-$51.6M	–	7533
2014 Q4	$51.6M	Buy	516,050 +362,588	+236%	+$28.2M	0.05%	343
2014 Q3	$10.1M	Sell	153,462 -91,103	-37%	-$5.98M	0.01%	1164
2014 Q2	$16.9M	Sell	244,565 -65,140	-21%	-$4.43M	0.02%	798
2014 Q1	$22.6M	Sell	309,705 -603,631	-66%	-$45M	0.03%	622
2013 Q4	$62.1M	Buy	913,336 +627,884	+220%	+$40.6M	0.06%	272
2013 Q3	$18M	Sell	285,452 -84,560	-23%	-$5.11M	0.02%	731
2013 Q2	$17.9M	Buy	+370,012	New	+$18.2M	0.02%	705

Barclays's CBST Position: Q1 2015 in Review

Barclays sold out of CUBIST PHARMACEUTICALS INC (CBST) in Q1 2015, closing a stake of 516,050 shares — an estimated $51.6M sold.

Barclays first reported a position in CBST in Q2 2013 and held it in 7 quarters. The position peaked at $62.1M in Q4 2013. 0 funds tracked by Wall St. Rank hold CBST as of Q1 2015.

Barclays reported no remaining CUBIST PHARMACEUTICALS INC position as of Q1 2015 after selling out during the quarter.
Barclays sold 516,050 CUBIST PHARMACEUTICALS INC shares in Q1 2015, an estimated $51.6M.
Barclays first reported a position in CUBIST PHARMACEUTICALS INC in Q2 2013 and held it in 7 quarters.
Barclays's CUBIST PHARMACEUTICALS INC position peaked at $62.1M in Q4 2013.
0 funds tracked by Wall St. Rank held CUBIST PHARMACEUTICALS INC as of Q1 2015.

Based on Barclays's 13F filing for Q1 2015, filed 14 May 2015.